VistaGen Therapeutics Inc. (VTGN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    VistaGen Therapeutics Inc...

    NASDAQ: VTGN · Real-Time Price · USD
    3.37
    -0.10 (-2.88%)
    At close: Sep 25, 2025, 3:59 PM
    3.26
    -3.26%
    After-hours: Sep 25, 2025, 07:36 PM EDT

    VistaGen Therapeutics Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 486K 1.06M -227K 1.11M 1.09M
    Cost of Revenue
    		 n/a n/a n/a 815.2K n/a
    Gross Profit
    		 486K 1.06M -227K 1.11M 1.09M
    Operating Income
    		 -55.97M -33.02M -59.27M -47.78M -17.93M
    Interest Income
    		 4.56M 3.35M 49K 20K 15K
    Pretax Income
    		 -51.41M -29.36M -59.24M -47.76M -17.93M
    Net Income
    		 -51.42M -29.36M -59.25M -47.76M -17.93M
    Selling & General & Admin
    		 17.08M 14.06M 14.66M 13.25M 7.1M
    Research & Development
    		 39.38M 20.02M 44.38M 35.41M 11.93M
    Other Expenses
    		 -635K n/a n/a 232K -400
    Operating Expenses
    		 55.82M 34.09M 59.04M 48.89M 19.02M
    Interest Expense
    		 n/a n/a 23K n/a 13K
    Selling & Marketing Expenses
    		 n/a n/a n/a 2.8M n/a
    Cost & Expenses
    		 56.46M 34.09M 59.04M 48.89M 19.02M
    Income Tax Expense
    		 7K 4K 6K 3.4K 2.6K
    Shares Outstanding (Basic)
    		 30.71M 19.35M 6.96M 6.6M 2.87M
    Shares Outstanding (Diluted)
    		 30.71M 19.35M 6.96M 6.6M 2.87M
    EPS (Basic)
    		 -1.67 -1.52 -8.51 -7.38 -14.74
    EPS (Diluted)
    		 -1.67 -1.52 -8.51 -7.38 -14.74
    EBITDA
    		 -55.34M -32.45M -58.74M -47.05M -17.44M
    EBIT
    		 -55.97M -33.02M -59.27M -47.76M -17.92M
    Depreciation & Amortization
    		 635K 568K 532K 711.1K 477.6K

    Add to Watchlist